| Short Description : | Mouse monoclonal antibody anti-BCA-225 is suitable for use in Immunohistochemistry research applications. |
| Applications: | IHC-P |
| Host: | Mouse |
| Reactivity: | Human |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Clonality : | Monoclonal |
| Clone ID : | Cu‐18 |
| Isotype: | IgG1/Kappa |
| Conjugation: | Unconjugated |
| Purification: | Affinity purified |
| Dilution Range: | 1:25‐100 |
| Formulation: | Tris-HCI buffer containing stabilizing protein (BSA) and <0.1% ProClin |
| Storage Instruction: | Store at 2‐8°C for up to 24 months. Predilute: Ready to use, no reconstitution necessary. Concentrate: Use dilution range and appropriate lab‐standardized diluent. Stability after dilution: 7 days at 24°C, 3 months at 2‐8°C, 6months at ‐20°C. |
| Immunogen: | A synthetic peptide |
| Specificity: | Positive control: Breast carcinoma, fallopian tube, or skin |
| Background | Anti-BCA-225 antibody recognizes a human breast carcinoma associated glycoprotein BCA-225 (220-225kD). This protein differs in size and distribution from other breast carcinoma antigens. Unlike other antibodies against breast carcinoma antigens, this antibody does not react with benign or malignant colonic, stomach, prostate, liver, pancreas, thyroid, or parotid tissues. Adenocarcinomas of the lung, ovary and endometrium also stain with this antibody. |
Information sourced from Uniprot.org
![Anti-BCA-225 antibody [Cu-18] (STJ16100310)](https://cdn11.bigcommerce.com/s-zso2xnchw9/images/stencil/600x533/products/149028/346635/STJ16100310_1__63899.1681998708.jpg?c=1 "Anti-BCA-225 antibody [Cu-18] (STJ16100310)")
